MET and chronic ulcer of skin: However, because proteolytic degradation of HGF impairs re-epithelialization in chronic skin ulcer patients [50] and restricted the therapeutic effects of HGF, non-native MET-agonists containing macrocyclic peptides have an advantage in treating chronic skin ulcers.